Tag Archives: Neurodegenerative Disorders

More on the Likely Association Between Air Pollution and Increased Risk of Dementia? (BMJ Open / NHS Choices / BBC News / PHE)

Posted on September 20, 2018 by Dementia and Elderly Care News

Summary Further evidence has emerged, from London, on the possible link between long-term exposure to air pollution and the likelihood of developing dementia. Full Text Link Reference Air pollution linked to dementia risk. London: NHS Choices; Behind the Headlines, September … Continue reading →

Vitamin D May Not Offer Protection Against Neurological Diseases? (NHS Choices / Nutritional Neuroscience / BJPsych Open)

Posted on July 14, 2018 by Dementia and Elderly Care News

Summary A recent systematic review of studies into the role of Vitamin D exposure levels / deficiency or supplementation in four neurodegenerative diseases (Alzheimer’s Disease, Motor Neurone Disease, Multiple Sclerosis (MS) and Parkinson’s Disease) found little conclusive evidence for any … Continue reading →

Posted in Animal Studies, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), In the News, International, NHS Choices, Parkinson's Disease, Quick Insights, Systematic Reviews, Universal Interest | Tagged 25-Dihydroxyvitamin D Levels, Adelaide Centre for Neuroscience Research: University of Adelaide, Adelaide Medical School: University of Adelaide, ALS: Amyotrophic Lateral Sclerosis, Alzheimer’s Disease, Amyotrophic Lateral Sclerosis, Amyotrophic Lateral Sclerosis (ALS), Australia, Australian Research Council Centre of Excellence for Nanoscale BioPhotonics: University of Adelaide, Bazian, Behind the Headlines, BJPsych Open (Journal), Canada, Critical Appraisals, Cumming School of Medicine: University of Calgary, Department of Family Medicine: University of Calgary, Department of Family Medicine: University of Newcastle, Diet and Dementia, Dietary Interventions, Dietary Risk Factors, Dietary Supplements, Endogenous Vitamin D From UV Exposure, Exogenously Derived Vitamin D From Supplementation, Faculty of Medicine: University of Newcastle (Australia), Mice, Motor Neurone Disease (MND), Mouse Model of Alzheimer's Disease, Multiple Sclerosis, Neurodegeneration, Neurodegenerative Disease Research, Neurodegenerative Diseases, Neurodegenerative Disorders, Neurological Disorders, Neuroprotection, Neuroprotection Research, Neuroprotective Agents, Neuroprotective Diets, Neuroprotective Lifestyles, Northern Clinical School: University of Sydney, Nutritional and Metabolic Disorders, Nutritional Neuroscience, Rehabilitation Studies Unit: University of Sydney, School of Medicine and Public Health: University of Newcastle (Australia), School of Psychology: University of South Australia, Social Work and Social Policy: University of South Australia, Sun Exposure, Sunlight Exposure, Sunridge Family Medicine Teaching Centre: University of Calgary, Supplementation (Dietary), Sydney Medical School: University of Sydney, Systematic Reviews and Meta-Analyses, Ultraviolet (UV) Exposure, Ultraviolet (UV) Radiation, University of Adelaide, University of Calgary, University of Newcastle (Australia), University of South Australia, University of Sydney, Vitamin D, Vitamin D Deficiency, Vitamin D Supplementation, Vitamin D Supplements | Leave a comment

Further Brief Insights Into the Potentially Neuroprotective Benefits of Certain Foods (BBC News / Scientific Reports / ARUK / AAIC)

Posted on April 28, 2018 by Dementia and Elderly Care News

Summary There is evidence to suggest that the protein β-parvalbumin found in fish inhibits the formation of α-synuclein (the protein present in Parkinson’s Disease). The cross-reaction of β-parvalbumin and human amyloidogenic proteins may explain at least some of the health … Continue reading →

Posted in Alzheimer’s Research UK, Charitable Bodies, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), International, Nutrition, Parkinson's Disease, Quick Insights, Statistics, UK, Universal Interest | Tagged 2017 Alzheimer’s Association International Conference (AAIC®2017), Abnormal Proteins (Alpha-Synuclein), Alpha-Synucleinopathies, Alzheimer's and Dementia: The Journal of the Alzheimer's Association, Alzheimer’s Association, Alzheimer’s Association AAIC Press Office, Alzheimer’s Association International Conference (AAIC®2017), Alzheimer’s Research UK (ARUK), Amyloidogenic Proteins, Anti-Inflammatory (Foods), Antioxidants, ARUK: Alzheimer’s Research UK, Baltic Sea Diet, Berries, Beta-Carotene, Beta-Parvalbumin, Blueberries, BSD (Baltic Sea Diet), Chalmers University of Technology, Cognitive Performance in Older US Adults: Health and Retirement Study, Columbia University, CoSTREAM Project: EU's Horizon 2020 Research and Innovation Programme, DASH (Dietary Approaches to Stop Hypertension), Dementia Prevention, Dementia Risk Factors, Dementia Risk Prevention, Dementia Risk Reduction, Dementia Risk Reduction and Prevention, Department of Biology and Biological Engineering: Chalmers University of Technology, Diet, Diet and Dementia, Dietary Approaches to Stop Hypertension (DASH) Diets, Dietary Behaviour, Dietary Factors, Dietetic Input, Dr David Reynolds: Alzheimer's Research UK, Eating Leafy Greens, Environmental Risk Factors, Epidemiology, Epidemiology and Statistics, Fish, Fish Consumption, Flavonoids, Health and Retirement Study (HRS), Health and Retirement Study (US), Healthy Behaviours, Healthy Eating, Healthy Lifestyles, Healthy Living, Healthy Nordic Diet, HRS: Health and Retirement Study, Inflammation-Related Nutrient Pattern (INP), Inflammatory Nutrient Pattern Associated With Cognitive Brain Ageing, α-Synuclein, α-Synuclein Misfolds, β-Parvalbumin, Karolinska Institute, Karolinska Institutet, Leafy Greens, Lifestyle Risk Factors, Mediterranean and DASH (Dietary Approaches to Stop Hypertension) Diets, Mediterranean Diet, Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND Diets), Modifiable Risk Factors, National Institutes of Health / National Institutes on Aging, Neurodegenerative Disease Research, Neurodegenerative Diseases, Neurodegenerative Disorders, Neuroprotection, Neuroprotection Research, Neuroprotective Agents, Neuroprotective Dietary Patterns Associated With Better Cognitive Performance, Neuroprotective Diets, Neuroprotective Lifestyles, Nordic Prudent Diet Reduces Risk of Cognitive Decline, Nordic Prudent Dietary Pattern (NPDP), Parkinson’s Disease Pathogenesis, Poor Diet Linked to Inflammation, Prevention, Prevention Agenda, Prevention of Dementia, Prevention of Parkinson’s Disease, Sweden, Synucleinopathy, The Health and Retirement Study, US National Institute on Aging, Wake Forest School of Medicine in Winston-Salem (North Carolina), Women Who Eat Well Less Likely to Develop Dementia, Women’s Health Initiative Memory Study (WHIMS) | Leave a comment

Diagnosis of Primary Progressive Aphasia (JGCR / Journal of Neurology / ARUK)

Posted on April 2, 2018 by Dementia and Elderly Care News

A Journal of Geriatric Care and Research (JGCR) case report discusses the neuropsychological assessments preparatory to the differential diagnosis of Primary Progressive Aphasia (PPA). PPA is a rare form of non-Alzheimer’s dementia featuring language impairment with progressive decline in word … Continue reading →

Preventative Treatment to Reduce Risk of Alzheimer’s Disease, Using Non-Steroidal Anti-Inflammatory Drugs? (NHS Choices / Journal of Alzheimer’s Disease)

Posted on March 31, 2018 by Dementia and Elderly Care News

Summary A recent article suggests that use of nonsteroidal anti-inflammatory drugs (NSAIDs) might help to reduce the risk of developing Alzheimer’s Disease, if prescription were to be commenced years before clinical signs were to develop. An NHS Choices Behind the … Continue reading →

Posted in For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), In the News, International, NHS Choices, Pharmacological Treatments, Quick Insights, Universal Interest | Tagged Aβ42, Alzheimer Disease Anti-Inflammatory Prevention, Alzheimer’s Disease Biomarkers, Amyloid Beta (Aβ42), Amyloid Beta Protein, Amyloid Cascade Inflammatory Hypothesis, Amyloid-β (Aβ), Amyloidogenic and Inflammatory Pathways, Aurin Biotech, Aurin Biotech Inc. Ltd. (Vancouver), ß-amyloid, Bazian, Behind the Headlines, Biomarkers, Canada, Critical Appraisals, Dementia Risk Reduction and Prevention, Dementia Saliva Testing (Pilot Study), Diagnosis of Alzheimer's Disease Based on Salivary Amyloid-β Protein 42 Levels, ELISA Method to Determine Aβ42 Levels in Saliva, Fluid Biomarker Analysis, Ibuprofen, Ibuprofen and the Reduced Risk of Alzheimer’s Disease Link, Inflammation, Journal of Alzheimer's Disease, Long-Term Ibuprofen Use, Neurodegenerative Disease Research, Neurodegenerative Diseases, Neurodegenerative Disorders, Neurodegenerative Research, Neuroinflammation, Non-Invasive Biomarkers, Non-Steroidal Anti-Inflammatory Drugs (NSAIDS), NSAIDS: Non-Steroidal Anti-Inflammatory Drugs, Preclinical Biomarkers in Alzheimer's Disease, Preventative Interventions, Prevention, Saliva Tests, Salivary Amyloid-β Protein 42 Levels, Salivary Biomarkers | Leave a comment

Dementia Researchers Recognised and Rewarded (BBC News / Lundbeck Foundation)

Posted on March 7, 2018 by Dementia and Elderly Care News

Summary Four dementia researchers share the 2018 (€1 million Euro) Brain Prize (bestowed by the Lundbeck Foundation), in recognition of their joint work on the underlying neuropathological mechanisms thought to cause of Alzheimer’s Disease. Full Text Link Reference Roberts, M. … Continue reading →

Posted in BBC News, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), In the News, International, Quick Insights, UK, Universal Interest | Tagged Abnormal Proteins, Abnormal Proteins (Tau), Alzheimer’s Disease, Alzheimer’s Disease and Dementia, Alzheimer’s Disease: Causes, Amyloid Beta Protein, Amyloid Cascade Hypothesis, Amyloid Proteins, Amyloid-β Protein, Annual €1 Million Brain Prize, Apolipoprotein E (APOE) Gene, Asymptomatic Alzheimer’s Disease, Cambridge University, Dementia Research, Dementia Research Careers, Dementia Research Funding, Genetic Research, Germany, Global Context, Global Dementia Research, Global Outlook, β-Amyloid Precursor Protein (APP), Lundbeck Foundation (Denmark), Neurodegeneration, Neurodegenerative Disease Research, Neurodegenerative Diseases, Neurodegenerative Disorders, Neuropathologic Disorders, Neuropathology, Pathophysiological Processes in Alzheimer’s Disease, Professor Bart De Strooper: Director of the UK Dementia Research Institute (UK DRI), Professor Christian Haass, Professor John Hardy, Professor Michael Goedert, The Brain Prize (Lundbeck Foundation), UK Dementia Research Institute, UK Dementia Research Institute (UK DRI), UK Dementia Research Institute at UCL, University College London, University of Munich | Leave a comment

The Most Significant Breakthrough in the Treatment of Neurodegenerative Diseases in Fifty Years? (BBC News / UCL)

Posted on December 15, 2017 by Dementia and Elderly Care News

Summary An experimental drug for the treatment of Huntington’s Disease shows early signs of being able to lower the level of misfolded proteins (safely) in the brains of patients, thereby having the potential to slow or halt the progression of … Continue reading →

Posted in BBC News, For Carers (mostly), For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), In the News, Parkinson's Disease, Quick Insights, UK, Universal Interest | Tagged Alzheimer's Disease, Amyloid Beta, Amyloid Beta Protein, Amyloid Proteins, Antisense Oligonucleotides (ASO), Biomedical Research Centres (NIHR), Canada, Clinical Trial NCT02519036, Gene Silencing to Suppress Transcription and Translation of Huntingtin, Gene-Silencing, Genetic Research, Genetics, Germany, Huntingtin Protein, Huntingtin Protein (HTT), Huntington Disease, Huntington's Disease (HD): an Autosomal-Dominant Inherited Neurodegenerative Disorder, Huntington's Disease Centre: UCL Institute of Neurology, Huntington’s Disease, Ionis Pharmaceuticals, IONIS-HTTRx: Huntingtin-Lowering Drug, α-Synuclein, α-Synuclein Aggregation, Leonard Wolfson Experimental Neurology Centre (LWENC), Leonard Wolfson Experimental Neurology Centre: University College London, Misfolded Proteins, Mutant HTT (mHTT) Protein, Mutant Huntingtin (mHTT), National Institute for Health Research (NIHR), Neurodegeneration, Neurodegenerative Disease Research, Neurodegenerative Diseases, Neurodegenerative Disorders, Neuronal Loss, Neuroprotection, Prof. Giovanna Mallucci, Professor Sarah Tabrizi: IONIS-HTTRx Global Chief Investigator, Professor Sarah Tabrizi: UCL Institute of Neurology, Protein Misfolding, Roche, Synucleinopathy, Tau, Tau Protein, Tauopathy, University College London (UCL), University College London Hospitals Biomedical Research Centre, University College London Hospitals NHS Foundation Trust, University College London Hospitals NHS Foundation Trust / University College London (NIHR) Biomedical Research Centre | Leave a comment

Tag Archives: Neurodegenerative Disorders

Preventative Treatment to Reduce Risk of Alzheimer’s Disease, Using Non-Steroidal Anti-Inflammatory Drugs? (NHS Choices / Journal of Alzheimer’s Disease)

Dementia Researchers Recognised and Rewarded (BBC News / Lundbeck Foundation)

The Most Significant Breakthrough in the Treatment of Neurodegenerative Diseases in Fifty Years? (BBC News / UCL)

Recent Posts

Archives

Categories

Google Translate (100+ Languages)

Recommended Sites